M001F-GCSFMOZ2
M001F-MOZ-1
M001F-GCSFMOZ1
M001F-GCSF-2
M001F-GCSF-3
M001F-GCSF4KIT
M001F-GCSFMOZ2EA
0
EUR
InStock
M001F-GCSFMOZ2
M001F-MOZ-1
M001F-GCSFMOZ1
M001F-GCSF-2
M001F-GCSF-3
M001F-GCSF-4
Human mobilised peripheral blood, Leukopak
Cellules
A Leukopak is an enriched leukapheresis product collected from normal peripheral blood. It is composed of a variety of blood cells including monocytes, lymphocytes, platelets, plasma, and red cells. A leukopak contains a higher concentration of cells as compared to standard venipuncture collection methods or buffy coat products.
- Test negative for Hepatitis B, C, HIV, HTLV, HCV/HBV, WNV, Trypanasoma cruzi, and Syphilis
Leukopaks from mobilised peripheral blood are collected from healthy human donors under IRB approved informed consent by leukapheresis using the COBE® Spectra or Spectra Optia® Apheresis System MNC collection protocol. Donors are injected with a combination of Mozobil® and G-CSF (Neupogen® - FDA approved), which stimulates the bone marrow to produce a large number of hematopoietic and progenitor stem cells and mobilises them into the peripheral blood stream. Mozobil® alone and G-CSF only protocols are also available. This mononuclear cell-rich leukapheresis product is extracted using continuous flow centrifugal technology directly into the collection bag.
Storage: Use immediately upon receipt.
Attention: Intended for research use only and not for direct therapeutic or diagnostic use in human or animals, or for further manufacturing of therapeutic products or devices.